<DOC>
	<DOCNO>NCT02936804</DOCNO>
	<brief_summary>The present study single arm clinical trial aim improve key technology diagnosis treatment early stage lung cancer . 60,000 high-risk subject ( age 45-70 ) plan recruit assign Low Dose Computed Tomography ( LDCT ) screen arm ( Baseline + 2 round biennial repeat LDCT screen ) . Management positive screen test carry pre-specified protocol .</brief_summary>
	<brief_title>Precision Diagnosis Therapy Early Stage Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>• Eligible participant age 4570 year , either follow risk factor : 1. history cigarette smoke ≥ 20 packyears , , former smoker , quit within previous 15 year ; 2. malignant tumor history immediate family member ; 3. personal cancer history ; 4. professional exposure carcinogen ; 5. long term exposure secondhand smoke ; 6. long term exposure cook oil fume . 1 . Had CT scan chest within last 12 month 2 . History cancer within 5 year</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>early stage lung cancer</keyword>
	<keyword>LDCT screening</keyword>
	<keyword>lung resection</keyword>
	<keyword>electromagnetic navigation bronchoscopy</keyword>
	<keyword>peripheral biomarker</keyword>
</DOC>